ELISE SCHUTT: Open Payments
NPI 1215237565 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,618 in 132 payments from 31 companies in 2025. Trend: 2023 $1,597 · 2024 $2,042 · 2025 $2,618
Food & beverage: $2,618
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $309 |
| AstraZeneca Pharmaceuticals LP | 6 | $252 |
| PFIZER INC. | 12 | $198 |
| Amgen Inc. | 14 | $170 |
| Novo Nordisk Inc | 9 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $149 |
| ABIOMED | 1 | $144 |
| Janssen Pharmaceuticals, Inc | 3 | $141 |
| Axsome Therapeutics, Inc. | 11 | $140 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $139 |
Products named: UBRELVY, AIRSUPRA, CAPLYTA, NURTEC ODT, SPRAVATO, Auvelity, TRELEGY ELLIPTA, Arikayce.
Industry payments across IN — which companies pay providers there.
